Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD

Autor:	Shoshana H. Ballew, Morgan E. Grams, Tessa K. Novick, Lesley A. Inker, Jung Im Shin, Aditya Surapaneni, G. Caleb Alexander, Alex R. Chang
Rok vydání:	2018
Předmět:	Male medicine.medical_specialty Epidemiology Population 030232 urology & nephrology MEDLINE Renal function Pain urologic and male genital diseases Critical Care and Intensive Care Medicine 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Internal medicine medicine Research Letter Humans In patient 030212 general & internal medicine Renal Insufficiency Chronic education Transplantation education.field_of_study Analgesics business.industry Anti-Inflammatory Agents Non-Steroidal Chronic pain Pain management Middle Aged medicine.disease female genital diseases and pregnancy complications Drug Utilization Analgesics Opioid Opioid chemistry Nephrology Female Gabapentin business medicine.drug Gabapentinoid
Zdroj:	Clinical journal of the American Society of Nephrology : CJASN. 13(12)
ISSN:	1555-905X
Popis:	Over 60% of individuals with CKD have chronic pain, a prevalence two to three times that of the general population ([1][1]). Although the pharmacologic treatment of pain among individuals with normal kidney function is often challenging, pain management in people with CKD is even more complicated ([
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8db1db0a86302b2ba8d0471df42d836 https://pubmed.ncbi.nlm.nih.gov/30409899 Zobrazit plný text záznamu